Stock Events

HLB Panagene. 

₩2,920
2
+₩0+0% Today

Statistics

Day High
2,960
Day Low
2,900
52W High
5,450
52W Low
2,800
Volume
22,408
Avg. Volume
183,403
Mkt Cap
121.61B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

31DecExpected
Q1 2017
Q2 2017
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
-139.83
-95.45
-51.07
-6.7
Expected EPS
N/A
Actual EPS
-62.9143

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 046210.KQ. It's not an investment recommendation.
Alphabet
78395
GOOGL
Apple
68177
AAPL
Microsoft
63621
MSFT
Amazon
59331
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Qiagen NV
QGEN
Mkt Cap10.16B
QIAGEN N.V. offers similar molecular diagnostics and research products, competing in the PCR and NGS-based product markets.
Illumina
ILMN
Mkt Cap20.93B
Illumina, Inc. provides genomic sequencing and array-based technologies, directly competing in the genetic analysis sector.
Thermo Fisher Scientific
TMO
Mkt Cap234.95B
Thermo Fisher Scientific Inc. offers extensive biotechnology product lines, including reagents and instruments for genetic research and diagnostics.
Repligen
RGEN
Mkt Cap8.45B
Repligen Corporation produces bioprocessing technologies and equipment, competing in the production of tools for biological research.
Bio-Rad Laboratories
BIO
Mkt Cap9.35B
Bio-Rad Laboratories, Inc. specializes in the production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications.
Agilent Technologies
A
Mkt Cap41.06B
Agilent Technologies, Inc. provides instruments, services, and consumables for labs, competing in genomics and molecular diagnostics.
Quest Diagnostics
DGX
Mkt Cap17.47B
Quest Diagnostics Incorporated offers diagnostic testing services, including for genetic disorders, directly competing in the diagnostics sector.
PERKINELMER INC
PKI
Mkt Cap16.9B
PerkinElmer Inc. provides analytical instruments, genetic testing and diagnostic tools, and reagents for research and clinical applications.
Guardant Health
GH
Mkt Cap3.15B

About

Panagene Inc. develops products in the field of molecular diagnostics in South Korea. Its products include Liquid biopsy products for lung and colon cancers; tissue biopsy products for lung, thyroid, pancreatic, and colon cancers, as well as glioblastoma, myeloproliferative neoplasm, chronic myelogenous leukemia, central nervous system, myelofibrosis, and polycythemia vera diseases. The company also offers products for cervical cancer, sexually transmitted, and extreme drug resistance diseases; and peptide nucleic acid products. The company was formerly known as Koram Panagene Ltd. and changed its name to Panagene Inc. in January 2009. Panagene Inc. was incorporated in 1976 and is based in Daejeon, South Korea.
Show more...
CEO
Byung-Hoon Lee
Employees
63
Country
KR
ISIN
KR7046210001

Listings

KQ
KR
046210.KQ